The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

(U.S.) $1.74

Today's change-0.20 -10.06%
Updated February 22 12:15 PM -5GMT. Delayed by at least 15 minutes.
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

(U.S.) $1.74

Today's change-0.20 -10.06%
Updated February 22 12:15 PM -5GMT. Delayed by at least 15 minutes.

Sharp drop following new 100-day high

Galectin Therapeutics Inc is sharply lower today, dropping (U.S.)$0.20 or 10.06% to (U.S.)$1.74 after setting a new 100-day high. Over the last five days, shares have gained 18.69% and 78.08% year to date. Shares have outperformed the S&P 500 by 26.45% during the last year.

Key company metrics

  • Open(U.S.) $1.84
  • Previous close(U.S.) $1.94
  • High(U.S.) $2.21
  • Low(U.S.) $1.63
  • Bid / Ask(U.S.) $1.72 / (U.S.) $1.75
  • YTD % change+78.08%
  • Volume1,865,864
  • Average volume (10-day)1,096,837
  • Average volume (1-month)608,841
  • Average volume (3-month)396,074
  • 52-week range(U.S.) $0.49 to (U.S.) $3.05
  • Beta2.63
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.83
Updated February 22 12:15 PM -5GMT. Delayed by at least 15 minutes.

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue--0----
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense5675
Selling / general / administrative1122
Research & development3443
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5-6-7-5
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-6-7-5
Income after tax-5-6-7-5
Income tax, total--------
Net income-5-6-7-5
Total adjustments to net income-1000
Net income before extra. items-5-6-7-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-6-7-5
Inc. avail. to common incl. extra. items-6-6-7-5
Diluted net income-6-6-7-5
Dilution adjustment--------
Diluted weighted average shares29292926
Diluted EPS excluding extraordinary itemsvalue per share-0.19-0.20-0.24-0.19
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.19-0.20-0.24-0.19